Strategic Global Investments Inc. Announces the Addition of Dr. Monique Barbour to the Board of Directors
September 13, 2017 11:59 ET
|
Strategic Global Investments, Inc.
DOVER Del., Sept. 13, 2017 (GLOBE NEWSWIRE) -- Strategic Global Investments, Inc. - (OTC Pink:STBV) /(Counterparty DEX:STBV) https://xchain.io/asset/STBV, a cryptocurrency/blockchain ICO company, is...
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
September 05, 2017 16:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend...
Istation CMO Ossa Fisher Accepted into Forbes Communications Council
August 28, 2017 08:12 ET
|
Istation Inc.
Dallas, Aug. 28, 2017 (GLOBE NEWSWIRE) -- Ossa Fisher, CMO and Deputy COO of Istation, has been accepted into the Forbes Communications Council, an invitation-only community for communications,...
Avid Bioservices to Exhibit at The Bioprocessing Summit 2017
August 16, 2017 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), today announced that the company...
Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2017 and Recent Developments
July 14, 2017 16:13 ET
|
Peregrine Pharmaceuticals Inc.
-- Avid Achieves Year-Over-Year Topline Revenue Growth of 30% Exceeding $57 Million -- -- Recent Presentation Supports Bavituximab’s Potential to Improve Clinical Outcome for Immune Checkpoint...
Peregrine to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2017 After Market Close on July 14, 2017
July 07, 2017 16:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., July 07, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing high...
Warburg Pincus Advisor Tom Schodorf Joins Proof: “Unproven Marketing Impact Is a Tax on Growth, Profitability and Shareholder Value”
May 17, 2017 10:00 ET
|
Proof Mark, Inc.
NEW YORK, May 17, 2017 (GLOBE NEWSWIRE) -- “Unproven marketing and communications impact is a material business risk to growth and profitability that C-suites and boards of directors must address,”...
FinancialForce Appoints Former NetSuite CMO to Drive Next Stage of Growth
March 15, 2017 08:00 ET
|
FinancialForce.com, Inc.
SAN FRANCISCO, March 15, 2017 (GLOBE NEWSWIRE) -- FinancialForce, the leading Cloud ERP vendor on the Salesforce Platform, today announced the appointment of Fred Studer as Chief Marketing Officer....
Peregrine to Report Financial Results for Third Quarter of Fiscal Year 2017 After Market Close on March 13, 2017
March 06, 2017 08:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing...
Big Pharma CMOs capture strongest performance ratings for small molecule API manufacturing
February 09, 2017 11:00 ET
|
Industry Standard Research
CARY, NC--(Marketwired - February 09, 2017) - The 2nd edition of Industry Standard Research's (ISR's) Small Molecule API Contract Manufacturer Quality Benchmarking report reveals that the top...